prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2008
-
Imatinib v první linii léčby nemocných s nově diagnostikovanou chronickou myeloidní leukemií v chronické fázi
Transfúze a hematologie dnes, year: 2008, volume: 14, edition: 4
-
Importance of Some Lymphocyte Subpopulations and Markers of Thrombocyte Activation in Preeclampsia and Gestational Hypertension
PROCEEDINGS OF THE XXI EUROPEAN CONGRESS OF PERINATAL MEDICINE, year: 2008
-
Importance of some lymphocyte subpopulations and markers of thrombocyte activation in preeclampsia and gestational hypertension.
The Journal of Maternal-Fetal and Neonatal Medicine, year: 2008, volume: 21, edition: Suppl.1
-
Importance of some lymphocyte subpopulations and markers of thrombocyte activation in preeclampsia and gestational hypertension.
International Proceedinngs. XXI European congres of Perinatal Medicine, 10-13 September, 2008, Istanbul Turkey., year: 2008, number of pages: 4 s.
-
Intracoronary Delivery of Bone Marrow Cells of the Acutely Infarcted myokardium. Optimization of the Delivery Technique.
Cardiology, year: 2008, volume: 112, edition: 2
-
JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia
Blood, year: 2008, volume: 112, edition: 11
-
Jak2 mutation and an additional thrombophilic state are major prothrombotic risk factors in myeloproliferations with thrombocythemia - data from a registry of anagrelide-treated patients
Hematologica the hematolog journal, year: 2008, volume: 93, edition: 1
-
Kmenové buňky a onkologie
Onkologická péče, year: 2008, volume: 2
-
Komentář k účinkům dasatinibu u pacientů v blastické krizi chronické myeloidní leukemie
Farmakoterapie, year: 2008, volume: 14
-
Komentář ke klinickým doporučením ESMO pro diagnózu, léčbu a kontrolní sledování pacientů s chronickou myeloidní leukemií
Farmakoterapie, year: 2008, volume: 14